Literature DB >> 22463585

Microvascular endoglin (CD105) expression correlates with tissue markers for atherosclerotic plaque vulnerability in an ageing population with multivessel coronary artery disease.

Xiaofei Li1, Jelger J van der Meer, Chris M van der Loos, Hanneke J P Ploegmakers, Onno J de Boer, Rob J de Winter, Allard C van der Wal.   

Abstract

AIMS: Vulnerable atherosclerotic plaques are lesions with a high propensity to develop plaque disruption and superimposed thrombosis. No systematic studies have been carried out on tissue markers for plaque vulnerability throughout the entire coronary artery system at the end stages of coronary atherosclerosis. METHODS AND
RESULTS: Nine autopsied patients (mean age 77 years) with angiographically severe trivascular coronary atherosclerosis were selected for this study. All visible lesions in postmortem coronary angiograms (n = 125) were histologically and immunohistochemically screened for the presence of intraplaque haemorrhages (activated) microvessels and inflammatory infiltrates. Intraplaque haemorrhages were observed in 76/125 plaques (61%). Chronic inflammation was found superficially in 59/125 plaques (47%) and deeply inside the plaque tissue in 103/125 plaques (83%). Microvessels were found in 100/125 lesions (80%), of which 58% showed endothelial expression of the vascular activation marker CD105. Moreover, microvascular CD105 positivity correlated positively with plaque haemorrhage and deeply seated plaque inflammation.
CONCLUSIONS: Plaque inflammation and haemorrhages can be found at a high frequency throughout the coronary artery system of elderly patients with multivessel coronary atherosclerosis. Microvascular expression of endoglin (CD105), which correlates positively with both of these features of plaque vulnerability, can serve as a marker of the risk of developing coronary thrombotic complications.
© 2012 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22463585     DOI: 10.1111/j.1365-2559.2011.04166.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  6 in total

1.  Endoglin/CD105-Based Imaging of Cancer and Cardiovascular Diseases: A Systematic Review.

Authors:  Vincent Q Sier; Joost R van der Vorst; Paul H A Quax; Margreet R de Vries; Elham Zonoobi; Alexander L Vahrmeijer; Ilona A Dekkers; Lioe-Fee de Geus-Oei; Anke M Smits; Weibo Cai; Cornelis F M Sier; Marie José T H Goumans; Lukas J A C Hawinkels
Journal:  Int J Mol Sci       Date:  2021-04-30       Impact factor: 5.923

2.  Thrombus characteristics evaluated by acute optical coherence tomography in ST elevation myocardial Infarction.

Authors:  Erlend Eriksen; Jon Herstad; Kartika Ratna Pertiwi; Vegard Tuseth; Jan Erik Nordrehaug; Øyvind Bleie; Allard C van der Wal
Journal:  PLoS One       Date:  2022-04-11       Impact factor: 3.240

3.  A novel CD105 determination system based on an ultrasensitive bioelectrochemical strategy with Pt nanoparticles.

Authors:  Suyun Zeng; Sujun Wang; Li Wang; Lihua Yang; Zhenbo Chen; Zhiqing Liang
Journal:  Sensors (Basel)       Date:  2012-10-08       Impact factor: 3.576

4.  Association of circulating angiogenesis inhibitors and asymmetric dimethyl arginine with coronary plaque burden.

Authors:  David M Charytan; Angeles Cinelli; Elisabeth M Zeisberg
Journal:  Fibrogenesis Tissue Repair       Date:  2015-07-21

5.  Endoglin (CD105) is a more appropriate marker than CD31 for detecting microvessels in carotid artery plaques.

Authors:  Ryu Fukumitsu; Yasushi Takagi; Kazumichi Yoshida; Susumu Miyamoto
Journal:  Surg Neurol Int       Date:  2013-09-30

6.  Negative correlation between endoglin levels and coronary atherosclerosis.

Authors:  Haibin Chen; Yiping Wang; Bing Sun; Xunxia Bao; Yu Tang; Feifei Huang; Sibo Zhu; Jiahong Xu
Journal:  Lipids Health Dis       Date:  2021-10-03       Impact factor: 3.876

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.